|
|
|||||||||
Basic Science Investigation |
1 Hematology Branch, National Heart, Lung, and Blood Institute, Rockville, Maryland; 2 AIDS Institute, UCLA School of Medicine, Los Angeles, California; 3 Clinical Pharmacokinetics Research Laboratory, Pharmacy Department, NIH Clinical Center, Bethesda, Maryland; and 4 PET Imaging Section, NIH Clinical Center, Bethesda, Maryland
Correspondence: For correspondence or reprints contact: Robert E. Donahue, VMD, Hematology Branch, NHLBI, 5 Research Ct., Rockville, MD 20850. E-mail: donahuer{at}nhlbi.nih.gov Guest Editor: Sanjiv Gambhir
Noninvasive imaging of a reporter gene is a new and promising technique to quantify transgene expression after gene therapy. This study was performed to demonstrate visualization of lentiviral-marked cells by PET. Methods: We transduced nonhuman primate CD34+ hematopoietic cells with a lentiviral vector expressing a PET reporter gene, the mutant viral herpes simplex virus type 1thymidine kinase (HSV1-sr39tk) gene. 1-(2-Fluoro-2-deoxy-ß-D-arabinofuranosyl)-76Br-5-bromouracil (76Br-FBAU) was used as the substrate for the viral tk enzyme. Upon phosphorylation, 76Br-FBAU was retained by cells and imaged by PET. The long half-life of 76Br, 16.2 h, permitted us to perform extended pharmacokinetic and imaging studies. Results: 76Br-FBAU was retained in vascular tissues of the animals with transplanted tk lentiviral vectortransduced CD34+ cells. Elimination of 76Br-FBAU was through renal and hepatic excretion. Conclusion: Noninvasive molecular imaging using PET will help us, in the future, to define the contribution and distribution of cells and their progeny to tissue repair and development.
Key Words: 76Br-FBAU gene therapy PET nonhuman primates molecular imaging
This article has been cited by other articles:
![]() |
M. Johnson, B. D.W. Karanikolas, S. J. Priceman, R. Powell, M. E. Black, H.-M. Wu, J. Czernin, S.-C. Huang, and L. Wu Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor J. Nucl. Med., May 1, 2009; 50(5): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soulas, R. E. Donahue, C. E. Dunbar, D. A. Persons, X. Alvarez, and K. C. Williams Genetically Modified CD34+ Hematopoietic Stem Cells Contribute to Turnover of Brain Perivascular Macrophages in Long-Term Repopulated Primates Am. J. Pathol., May 1, 2009; 174(5): 1808 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. An, R. E. Donahue, M. Kamata, B. Poon, M. Metzger, S.-H. Mao, A. Bonifacino, A. E. Krouse, J.-L. Darlix, D. Baltimore, et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates PNAS, August 7, 2007; 104(32): 13110 - 13115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |